> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Alston Bird FDA Domestic Inspection Analysis
- URL: https://www.fdaweb.com/alston-bird-fda-domestic-inspection-analysis/
- Published: 2020-03-25T12:00:00.000Z
- Updated: 2026-09-14T16:08:49.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5146409

Alston Bird attorneys say that as a result of FDA’s 3/18 decision to temporarily postpone routine surveillance domestic inspections due to the coronavirus outbreak, regulated industry “must be prepared for FDA’s expanded use of its existing authorities, creative alternatives to ensure the safety of FDA-regulated products being produced in tens of thousands of manufacturing facilities across the globe, and continued modifications to FDA’s policies on both domestic and foreign inspections.” Its [analysis](https://www.jdsupra.com/legalnews/fda-temporarily-postpones-routine-26526/?ref=fdaweb.com) looks at the postponement of routine surveillance inspections, a continuation of “mission-critical” for-cause inspections, status of other FDA inspection types, and additional oversight tools available.

The attorneys say the FDA announcement highlighted the agency’s ability to request records in lieu of an on-site inspection when travel is not permissible.

The agency also declared that “inspections are not what cause quality to happen,” thus placing primary responsibility on regulated industry to produce safe and quality products, according to the analysis.